Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1354, 2002-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Patients with chronic fatigue syndrome gain no benefit from treatment with galantamine
Inpharma, Vol. 1, Iss. 1455, 2004-01 ,pp. :
Access to resources
Recommend
Neurotensin Agonists: Potential in the Treatment of Schizophrenia
By Boules Mona
CNS Drugs, Vol. 21, Iss. 1, 2007-01 ,pp. :
Galantamine treatment for AD warranted in Canada
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 339, 2001-01 ,pp. :